Current filters:  
Canada
Healthcare
Canada
Fasken
On September 21, 2022, the main provisions of the More Beds, Better Care Act ("Bill 7") and supporting regulations came into effect. Bill 7 amends the Fixing Long-Term Care Act...
Smart & Biggar
On September 1, 2022, the Canadian Agency for Drugs and Technologies in Health (CADTH) announced the launch of its Post-Market Drug Evaluation Program.
MLT Aikins LLP
The privacy commissioners said fax machines and unencrypted emails – along with snooping cases and ransomware attacks – have led to numerous privacy breaches in the health care sector.
Smart & Biggar
In a decision rendered on August 17, 2022, the Federal Court granted Sandoz Canada Inc (Sandoz) leave to amend its Statement of Defence to add new allegations...
Gowling WLG
September 2022 marks the fifth-year anniversary of Canada's Certificate of Supplementary Protection regime.
Torys LLP
Canada's medical device market is highly diversified and mature—providing great opportunity to manufacturers who wish to enter it. However, Canada also has some of the most stringent medical device laws in the world.
Blake, Cassels & Graydon LLP
In recent years, the plant-based food industry has seen significant growth, and new technologies continue to emerge. Blakes lawyers Vivian Kung and Robin Burns join us on the latest episode of our podcast...
Gowling WLG
On August 16, 2022, LiveFit North America Inc. operating as Ethey ("Ethey") announced that it had acquired Puppy Gang Fresh Foods Ltd. ("Puppy Gang").
MLT Aikins LLP
On July 6, 2022, the Canadian Food Inspection Agency ("CFIA") introduced changes to the Food and Drugs Regulations ("FDR") and Safe Food for Canadians Regulations ("SFCR").
Siskinds LLP
Businesses that advertise food products are subject to myriad regulations with respect to the claims they can make about their products.
Miller Thomson LLP
On July 18, 2022, in Kadri v. Windsor Regional Hospital ("Kadri") the Divisional Court dismissed the appeal of Dr. Kadri. Dr. Kadri's appeal was from the Health Professions Appeal and Review Board (HPARB) decision...
Smart & Biggar
Health Canada released a number of reports over the summer: Annual Health Product Highlights for 2021, which provides an overview of new health products, including drugs and medical devices...
Torys LLP
The federal government has amended the Food and Drug Regulations (FDR) and the Safe Food for Canadians Regulations (SFCR) to update the requirements for labelling...
Gowling WLG
In AbbVie Corporation v Canada (Health), 2022 FC 1209, Justice Fothergill of the Federal Court upheld the Minister of Health's finding that innovator pharmaceutical companies must actively market...
Keller & Heckman
As detailed in the press releases, Both MLs were initially proposed on April 9, 2021, and were open to comment for 75 days.
Smart & Biggar
JAMP therefore submitted the Form Vs, listing the non-marketed 40 mg/0.4 mL and 80 mg/0.8 mL high concentration HUMIRA as the reference drugs.
Bereskin & Parr LLP
Health Canada has now completed its initial review of the Biogen Alzheimer's Disease (AD) drug Aduhelm (aducanumab). Following the receipt of the initial Health Canada feedback...
Fasken
On August 18, 2022, PMPRB announced its Decision resulting from the consultation on the PMPRB Price Review Approach During the Interim Period following publication of Amendments to the Patented Medicines Regulation...
Blake, Cassels & Graydon LLP
On July 22, 2022, the Alberta Court of Appeal (the court) released its decision in Alberta Health Services v. Pawlowski. In the decision, the court affirmed the importance of precise and unambiguous language...
Fasken
This Regulation makes several new products including pharmaceutical products subject to extended producer responsibility.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Upcoming Events
Mondaq Social Media